Top compounds associated with response to CCP110


Feature Type Standardized
Nominal ANOVA
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.23 8e-10
mRNA RDEA119 GDSC1000 pan-cancer AAC -0.2 1e-09
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.22 2e-09
mRNA ABT-737 CTRPv2 pan-cancer AAC 0.22 2e-09
mRNA SRT-1720 CTRPv2 pan-cancer AAC 0.22 3e-09
mRNA GMX-1778 CTRPv2 pan-cancer AAC 0.22 3e-09
mRNA NPK76-II-72-1 GDSC1000 pan-cancer AAC 0.18 4e-09
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.21 5e-09
mRNA FH535 GDSC1000 pan-cancer AAC -0.21 5e-09
mRNA NSC95397 CTRPv2 pan-cancer AAC 0.19 6e-09
Download CSV